Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
No easy answers: European research consortia take on major challenges
GlobeNewswire, Inc.
COPENHAGEN, Denmark, July 10, 2026 (GLOBE NEWSWIRE) -- Nine new Challenge Programme grants from the Novo Nordisk Foundation will support ambitious research across fungal diseases, cardiometabolic disease, soil health and non-equilibrium biological...
VERAXA Biotech Provides Business Update and Further Details on Partnering Strategy and Development Timelines
GlobeNewswire, Inc.
ZURICH, SWITZERLAND – July 6, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today provided a company and pipeline update. “In the first six months of 2026, we have made substantial...
Molecular Partners Showcases Bispecific Radio-DARPins at Gordon Research Conference
GlobeNewswire, Inc.
Developing bispecific Radio-DARPins to engage multiple tumor targets simultaneously, improving precision and therapeutic efficacy Presentation outlines Radio-DARPins’ ability to match target and disease biology for improved outcomes...
Securosys Simplifies eIDAS 2.0 Remote Signing with Integrated SAM Functionality in Primus HSMs
EIN Presswire
Securosys enables eIDAS-compliant remote signing with integrated HSM and SAM functionality on a single platform for QTSPs and technology partners.
Precision Turned Product Manufacturing Market to Reach US$179.7 Billion by 2033, Says Persistence Market Research
EIN Presswire
Rising demand for precision components and increased adoption of CNC manufacturing technologies are driving market growth.
Santersus Advances NucleoCapture® into Multinational Pivotal Study in Sepsis
EIN Presswire
Up to 350-patient randomized NUC-CAP study to assess safety, organ support and organ dysfunction in sepsis; Axcellant appointed global CRO to support execution ZURICH, SWITZERLAND, October 22, 2026 /EINPresswire.com/ -- Santersus AG (“Santersus”...
Correction: ITM and Lumara Bio Announce Dose-Response Analysis for ¹⁷⁷Lu-edotreotide (ITM-11) and Data Supporting Early-Stage Pipeline at EANM 2026
GlobeNewswire, Inc.
Dose-response analysis from Phase 3 COMPETE trial shows an association between higher absorbed doses of ¹⁷⁷Lu-edotreotide in tumors and improved clinical response in GEP-NETs Separate independent, investigator-led studies highlight promising...
ITM and Lumara Bio Announce Dose-Response Analysis for ¹⁷⁷Lu-edotreotide (ITM-11) and Data Supporting Early-Stage Pipeline at EANM 2026
GlobeNewswire, Inc.
Dose-response analysis from Phase 3 COMPETE trial shows an association between higher absorbed doses of ¹⁷⁷Lu-edotreotide in tumors and improved clinical response in GEP-NETs Separate independent, investigator-led studies highlight promising...
VERAXA Biotech Initiates Cell Line Development with ATUM to Advance its Lead BiTAC®-TCE Program
GlobeNewswire, Inc.
ZURICH, SWITZERLAND – July 02, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the initiation of cell line development for its lead BiTAC® T-cell engager (BiTAC-TCE)...
netpulse AG Reveals New Findings on Brand Visibility in AI Chat Answers
GlobeNewswire, Inc.
WINTERTHUR, ZH, Oct. 23, 2026 (GLOBE NEWSWIRE) -- WINTERTHUR, ZH - October 22, 2026 - netpulse AG, a digital marketing agency based in Winterthur, a business city near Zurich in the German-speaking region of Switzerland, has released new findings...
SEALSQ and GlobalFoundries Partner to Accelerate Post-Quantum Cryptography and Quantum Computing Technologies
GlobeNewswire, Inc.
Geneva, Switzerland, July 08, 2026 (GLOBE NEWSWIRE) -- SEALSQ Corp (Nasdaq: LAES) ("SEALSQ") and GlobalFoundries (Nasdaq: GFS) (GF) today announced a strategic Memorandum of Understanding (MoU) to co-develop across secure semiconductor platforms,...
Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness
GlobeNewswire, Inc.
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 8, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric...
Roivant to Report Financial Results for the Second Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026
GlobeNewswire, Inc.
BASEL, Switzerland and LONDON and NEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, November 9, 2026, to report its financial results...
Anaveon Appoints Laetitia Pouzol as Chief Scientific Officer
GlobeNewswire, Inc.
BASEL, Switzerland, July 02, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage biotechnology company pioneering precision biologics to reprogram the immune system for the treatment of autoimmune and inflammatory diseases, today announced the...
Acronis Research and Development Wins Workforce Transformation Award at SGTech Industry Gala 2026
GlobeNewswire, Inc.
SINGAPORE, July 07, 2026 (GLOBE NEWSWIRE) -- Acronis, a global leader in cybersecurity and data protection, today announced that Acronis Asia Research and Development Pte Ltd has been named the SME category winner of the Workforce Transformation...
Swiss Water Reports Voting Results from Annual General and Special Meeting of Shareholders
GlobeNewswire, Inc.
VANCOUVER, British Columbia, May 21, 2026 (GLOBE NEWSWIRE) -- Swiss Water Decaffeinated Coffee Inc. (TSX : SWP) (“Swiss Water” or “the Company”), a leading specialty coffee company and premium green coffee decaffeinator, is pleased to announce the...
Political Uncertainty Fuels Demand for Additional Residence and Citizenship Rights
GlobeNewswire, Inc.
LONDON, Oct. 27, 2026 (GLOBE NEWSWIRE) -- New data shows a rising interest in additional residence and citizenship rights among wealthy families in some of the world's most established countries, as political, regulatory and social volatility...
SEALSQ to Showcase U.S. Quantum Investments and Strategic Collaborations at IQT Quantum + AI 2026 Event in New York
GlobeNewswire, Inc.
Geneva, Switzerland, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Company to highlight investments in U.S. quantum innovation and collaborations with MIT Media Lab, Lattice Semiconductor and GlobalFoundries SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"),...
Recloser Market Registering a CAGR of 6.2% By Driving Types, Applications, Technology and Trends, Forecast 2035
EIN Presswire
Asia-Pacific leads the Recloser Market at 38% global share, anchored by massive state-funded grid builds in China and India.
Coin Factory AG Sets December 8 Start Date for MGC Share-Claim Program
GlobeNewswire, Inc.
Coin Factory AG announces December 8 start date for Meta Games Coin (MGC) share-claim program.
Sign up for:
Switzerland Tech Review
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.